Cordycepin‐Enriched Cordyceps militaris Extract ARA815 Induces Ferroptosis in Lung Cancer Cells In Vivo and In Vitro
Molecular Nutrition & Food Research · 2026-04 · 70 (8)
DOI: 10.1002/mnfr.70477 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Nutrition & Food Research, online erschienen am 25.04.2026. Verfasst von Mina Boo und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Science in Korean Medicine, Graduate School, Kyung Hee University, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Ferroptosis, Cordyceps, Deoxyadenosines, Lung Neoplasms. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Seoul R&BD Program.
Abstract (Originalsprache)
Cordyceps militaris , a traditional medicinal fungus and a promising food supplement, has demonstrated anticancer potential, yet its underlying mechanisms and in vivo efficacy remain poorly defined. Previously, we developed an optimized extraction and preparation protocol to enrich the bioactive content of C. militaris , specifically adenosine and cordycepin. Here, using this optimized C. militaris extract (CME), we investigated its antitumor effects and underlying mechanisms in a murine lung cancer model. Components of CME were quantified using high‐performance liquid chromatography. In vivo, CME significantly suppressed tumor growth in LLC1‐bearing mice. Mechanistically, CME induced ferroptosis, an iron‐dependent form of regulated cell death characterized by lipid peroxidation and redox imbalance. Tumors from CME‐treated mice displayed elevated lipid ROS, increased iron accumulation, glutathione depletion, and downregulation of glutathione peroxidase 4. Apoptotic signaling was accompanied with ferroptosis, but neither pyroptosis nor necroptosis contributed to CME‐induced lung cancer death. Pharmacological rescue experiments confirmed the specificity of ferroptosis as the dominant mode of cell death. Importantly, CME caused no systemic toxicity, and its approximate lethal dose was over 5000 mg/kg. Together, these findings suggest CME as a potent ferroptosis‐inducing agent against lung cancer and establish C. militaris as a promising candidate for redox‐targeted cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Science in Korean Medicine, Graduate School, Kyung Hee University, Seoul, Republic of Korea.
- Bioara Co., Ltd, Seoul, Republic of Korea.
- Department of Pharmacology, College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea.
- School of Biological Sciences, College of Science, Nanyang Technological University, Singapore, Singapore.
- Institute of Wonkwang Medical Science and Department of Microbiology, Wonkwang University School of Medicine, Iksan, Republic of Korea.
- Department of Biochemistry, College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea.
Förderung
- Seoul R&BD Program
Zitieren
APA
Boo, M., Sim, J. H., Kim, H., Kim, H., Choi, H., An, S., Yang, H., Youn, D. H., Yang, M., Park, S. J., Han, Y., Jung, J. H., Kim, W., Kim, K. I., Lee, K., Kim, H. L., Kim, H. I., & Park, J. (2026). Cordycepin‐Enriched Cordyceps militaris Extract ARA815 Induces Ferroptosis in Lung Cancer Cells In Vivo and In Vitro. Molecular Nutrition & Food Research, 70(8). https://doi.org/10.1002/mnfr.70477
Vancouver
Boo M, Sim JH, Kim H, Kim H, Choi H, An S, et al. Cordycepin‐Enriched Cordyceps militaris Extract ARA815 Induces Ferroptosis in Lung Cancer Cells In Vivo and In Vitro. Molecular Nutrition & Food Research. 2026;70(8). doi:10.1002/mnfr.70477
BibTeX
@article{Boo2026,
author = {Boo, Mina and Sim, Jae Heon and Kim, HyoJeong and Kim, Harim and Choi, Hyunyoung and An, Suhyeon and Yang, HyunSoo and Youn, Dong-Hyun and Yang, Mingxiao and Park, Su Jin and Han, Yohan and Jung, Ji Hoon and Kim, Woojin and Kim, Kwan-Il and Lee, Kyungjin and Kim, Hye-Lin and Kim, Hyo In and Park, Jinbong},
title = {Cordycepin‐Enriched Cordyceps militaris Extract ARA815 Induces Ferroptosis in Lung Cancer Cells In Vivo and In Vitro},
journal = {Molecular Nutrition & Food Research},
year = {2026},
volume = {70},
number = {8},
doi = {10.1002/mnfr.70477}
}
EUVIMED